Frequency of human parvovirus 4 (PARV4) viremia among HBV-infected patients and healthy donors in Shiraz, Iran

Frequency of human parvovirus 4 (PARV4) viremia among HBV-infected patients and healthy donors in Shiraz, Iran

Background/aim: PARV4, a small DNA virus belonging to the family Parvoviridae, was first isolated in an HBV injecting drug user. Several studies have investigated PARV4 co-infection with HBV and HCV and its effect on the progression of liver disease. The aim of this study was to determine the frequency of PARV4 among HBV-infected patients and healthy individuals. Materials and methods: A group of 90 HBV patients and a group of 90 healthy subjects were included in this study. Samples were selected after screening tests such as HBsAg ELISA, anti-HCV ELISA, and anti-HIV ELISA. Nested-PCRs were conducted to detect the PARV4 genome. Positive samples were then subjected to DNA sequencing. Results: PARV4 DNA was detected in 4.4% of HBV patients in comparison with 1.1% of healthy individuals (P-value: 0.36). DNA sequencing results revealed that PARV4 in all five positive samples was genotype I. Conclusions: Although this pilot study showed no significant difference between the frequency of PARV4 among HBV patients and healthy donors, further studies with a larger sample size are suggested to determine the association of PARV4 with HBV co-infection and the impact of this virus on the progression of liver disease in patients with hepatitis B.

___

  • 1. Jones MS, Kapoor A, Lukashov VV, Simmonds P, Hecht F, Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J Virol 2005; 79: 8230-8236.
  • 2. Simmonds P, Douglas J, Bestetti G, Longhi E, Antinori S, Parravicini C, Corbellino M. A third genotype of the human parvovirus PARV4 in sub-Saharan Africa. J Gen Virol 2008; 89: 2299-2302.
  • 3. Fryer JF, Kapoor A, Minor PD, Delwart E, Baylis SA. Novel parvovirus and related variant in human plasma. Emerg Infect Dis 2006; 12: 151-154.
  • 4. Fryer JF, Delwart E, Bernardin F, Tuke PW, Lukashov VV, Baylis SA. Analysis of two human parvovirus PARV4 genotypes identified in human plasma for fractionation. J Gen Virol 2007; 88: 2162-2167.
  • 5. Botto S, Bergallo M, Sidoti F, Terlizzi ME, Astegiano S, Ponti R, Costa C, Cavallo R. Detection of PARV4, genotypes 1 and 2, in healthy and pathological clinical specimens. New Microbiol 2009; 32: 189-192.
  • 6. Simmonds P, Manning A, Kenneil R, Carnie FW, Bell JE. Parenteral transmission of the novel human parvovirus PARV4. Emerg Infect Dis 2007; 13: 1386-1388.
  • 7. Lurcharchaiwong W, Chieochansin T, Payungporn S, Theamboonlers A, Poovorawan Y. Parvovirus 4 (PARV4) in serum of intravenous drug users and blood donors. Infection 2008; 36: 488-491.
  • 8. Sharp CP, Lail A, Donfield S, Simmons R, Leen C, Klenerman, P, Delwart E, Gomperts ED, Simmonds P. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies. J Infect Dis 2009; 200: 1119-1125.
  • 9. Drexler JF, Reber U, Muth D, Herzog P, Annan A, Ebach F, Sarpong N, Acquah S, Adlkofer J, Adu-Sarkodie Y et al. Human parvovirus 4 in nasal and fecal specimens from children, Ghana. Emerg Infect Dis 2012; 18: 1650-1653.
  • 10. Sharp CP, Vermeulen M, Nebie Y, Djoko CF, LeBreton M, Tamoufe U, Rimoin AW, Kayembe PK, Carr JK, ServantDelmas A et al. Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa. Emerg Infect Dis 2010; 16: 1605-1607.
  • 11. Benjamin LA, Lewthwaite P, Vasanthapuram R, Zhao G, Sharp C, Simmond P, Wang D, Solomon T. Human parvovirus 4 as potential cause of encephalitis in children, India. Emerg Infect Dis 2011; 17: 1484-1487.
  • 12. Chen MY, Yang SJ, Hung CC. Placental transmission of human parvovirus 4 in newborns with hydrops, Taiwan. Emerg Infect Dis 2011; 17: 1954-1956.
  • 13. Manning A, Willey SJ, Bell JE, Simmonds P. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis 2007; 195: 1345-1352.
  • 14. Schneider B, Fryer JF, Reber U, Fischer HP, Tolba RH, Baylis SA, Eis-Hubinger AM. Persistence of novel human parvovirus PARV4 in liver tissue of adults. J Med Virol 2008; 80: 345-351.
  • 15. Corcioli F, Zakrzewska K, Fanci R, De Giorgi V, Innocenti M, Rotellin M, Di Lollo S, Azzi A. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). Virol J 2010; 7: 272.
  • 16. Fryer JF, Delwart E, Hecht FM, Bernardin F, Jones MS, Shah N, Baylis SA. Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion 2007; 47: 1054-1061.
  • 17. Ma YY, Guo Y, Zhao X, Wang Z, Lv MM, Yan QP, Zhang JG. Human parvovirus PARV4 in plasma pools of Chinese origin. Vox Sang 2012; 103: 183-185.
  • 18. Simmons R, Sharp C, Sims S, Kloverpris H, Goulder P, Simmonds P, Bowness P, Klenerman P. High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J Infect Dis 2011; 203: 1378-1387.
  • 19. Simmons R, Sharp C, McClure CP, Rohrbach J, Kovari H, Frangou E, Simmonds P, Irving W, Rauch A, Bowness P et al. Parvovirus 4 infection and clinical outcome in high-risk populations. J Infect Dis 2012; 205: 1816-1820.
  • 20. Longhi E, Bestetti G, Acquaviva V, Foschi A, Piolini R, Meroni L, Magni C, Antinori S, Parravicini C, Corbellino M. Human parvovirus 4 in the bone marrow of Italian patients with AIDS. Aids 2007; 21: 1481-1483.
  • 21. Hsu TC, Chen TY, Lin MC, Tzang BS, Tsay GJ. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection. J Gastroen Hepatol 2005; 20: 733-738.
  • 22. Toan NL, Song le H, Kremsner PG, Duy DN, Binh VQ, Duechting A, Kaiser H, Torresi J, Kandolf R, Bock CT. Coinfection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection. J Hepatol 2006; 45: 361-369.
  • 23. Tong R, Shen L, Yin W, Zhou W, Lu J, Zheng M, Bi S, Lou Y, Tan W. Prevalence of human parvovirus B19, bocavirus, and PARV4 in blood samples from the general population of China and lack of a correlation between parvovirus and hepatitis B co-infection. Plos One 2013; 8: e64391.
  • 24. Yu X, Zhang J, Hong L, Wang J, Yuan Z, Zhang X, Ghildyal R. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in Shanghai. Plos One 2012; 7: e29474.
  • 25. Fryer JF, Lucas SB, Padley D, Baylis SA. Parvoviruses PARV4/5 in hepatitis C virus-infected patient. Emerg Infect Dis 2007; 13: 175-176.
  • 26. Touinssi M, Reynaud-Gaubert M, Gomez C, Thomas P, Dussol B, Berland Y, Basire A, Picard C, Cantaloube JF, de Micco P et al. Parvovirus 4 in French in-patients: a study of hemodialysis and lung transplant cohorts. J Med Virol 2011; 83: 717-720.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Analysis of epidemiology and risk factors for mortality in ventilator-associated pneumonia attacks in intensive care unit patients

Meltem Arzu YETKİN, Aliye BAŞTUĞ, Esragül AKINCI, Hürrem BODUR, Dilek KANYILMAZ, Pınar ÖNGÜRÜ, Adalet AYPAK, Halide ASLANER, Ayşe BUT, Nevzat Mehmet MUTLU

Sezin ÜNAL, Nuriye Ebru ERGENEKON, Ebru KAZANCI, Selma AKTAŞ, Ferit KULALI, İbrahim Murat HIRFANOĞLU, Canan TÜRKYILMAZ, Yildiz ATALAY

Screening of immunocompromised patients at risk of strongyloidiasis in western Turkey using ELISA and real-time PCR

Mert DÖŞKAYA, Mümtaz YILMAZ, Ayşe CANER, Hüseyin TÖZ, Hüsnü PULLUKÇU, Adnan Yüksel GÜRÜZ3, Hüseyin CAN, Esra ERDEM KIVRAK, Esra ATALAY ŞAHAR, Meltem IŞIKGÖZ TAŞBAKAN

The effect of acetylsalicylic acid on vasopressin, serum insulin levels, insulin resistance, and biochemical parameters in rats induced with experimental diabetes type 2

Sefa ÇELİK, Serkan ŞEN

Abdelgayoum Ahmed ABDEL-GAYOUM, Mohamed Hamza Sulaiman AHMIDA

Angel Arturo Lopez GONZALEZ, Zoe MANZANERO, Maria Teofila VICENTE-HERRERO, Sheila GARCIA-AGUDO, Maria GIL-LLINAS, Francisco MORENO-MORCILLO

Neslihan Hacer Dikmenoğlu FALKMARKEN, Okan ARIHAN, Alper Bektaş İSKİT

Rachid ELJAOUDI, Naoual ELOMRI, Meryem LAAMARTI, Yahia CHERRAH, Taoufik AMEZYANE, Driss GHAFIR, Azeddine IBRAHIMI

Derya Özer KAYA, Şeyda Toprak ÇELENAY

Performing ICSI with commercial microinjection pipettes enhanced pregnancy rates

Mohammad Ali KHALILI, Iman HALVAEI, Shahin GHAZALI, Mohammad Hossein RAZI